TipRanks
Alibaba Health Information Technology Ltd. (DE:TWY)
FRANKFURT:TWY
Germany Market
TWY
Alibaba Health Information Technology
RESEARCH TOOLSreports

Alibaba Health Information Technology (TWY) Stock Forecast & Price Target

2 Followers
See the Price Targets and Ratings of:

TWY Analyst Ratings

Strong Buy
4Ratings
Strong Buy
3 Buy
1 Hold
0 Sell
Based on 4 analysts giving stock ratings to
Alibaba
Health Information Technology
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

TWY Stock 12 Month Forecast

Average Price Target

€0.48
▲(45.22% Upside)
Based on 4 Wall Street analysts offering 12 month price targets for Alibaba Health Information Technology in the last 3 months. The average price target is €0.48 with a high forecast of €0.51 and a low forecast of €0.41. The average price target represents a 45.22% change from the last price of €0.33.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"0":"€0","1":"€1","-1":"-€1","-0.5":"-€0.5","0.5":"€0.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":0.5122215,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">€0.51</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":0.47921167,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">€0.48</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":0.4097772,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">€0.41</span>\n  </div></div>","useHTML":true}}],"tickPositions":[-1,-0.5,0,0.5,1],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jan<br/>2026","6":"Apr<br/>2026","9":"Jul<br/>2026","12":"Oct<br/>2026","25":"Oct<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,0.328,0.34217088461538464,0.35634176923076927,0.37051265384615384,0.38468353846153847,0.3988544230769231,0.4130253076923077,0.42719619230769235,0.4413670769230769,0.45553796153846154,0.46970884615384617,0.48387973076923074,0.49805061538461537,{"y":0.5122215,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,0.328,0.33963166692307695,0.3512633338461539,0.36289500076923076,0.3745266676923077,0.3861583346153846,0.39779000153846156,0.4094216684615385,0.42105333538461537,0.4326850023076923,0.44431666923076923,0.4559483361538461,0.46758000307692305,{"y":0.47921167,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,0.328,0.33429055384615386,0.3405811076923077,0.34687166153846155,0.3531622153846154,0.35945276923076924,0.3657433230769231,0.37203387692307693,0.3783244307692308,0.3846149846153846,0.39090553846153847,0.3971960923076923,0.40348664615384616,{"y":0.4097772,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":0.674,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.595,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.566,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.505,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.616,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.546,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.489,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.436,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.393,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.314,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.355,"date":1785542400000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":0.349,"date":1788220800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.328,"date":1790812800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target€0.51Average Price Target€0.48Lowest Price Target€0.41
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Jefferies Analyst forecast on DE:TWY
Hongda Zhong
Jefferies
Not Ranked
Jefferies
€0.51
Buy
55.22%
Upside
Reiterated
09/30/26
Wall Street Analysts Are Bullish on Top Healthcare Picks
Goldman Sachs Analyst forecast on DE:TWY
Lincoln Kong
Goldman Sachs
Goldman Sachs
€0.48→€0.41
Hold
24.17%
Upside
Reiterated
09/22/26
Analysts' Opinions Are Mixed on These Healthcare Stocks: Cardiol Therapeutics (NASDAQ: CRDL), Tyra Bioscience (NASDAQ: TYRA) and Alibaba Health Information Technology (Other OTC: ALBHF)
Huatai Securities Analyst forecast on DE:TWY
Unknown Analyst
Huatai Securities
Not Ranked
Huatai Securities
€0.48
Buy
46.25%
Upside
Reiterated
09/22/26
Huatai Securities Remains a Buy on Alibaba Health Information Technology (ALBHF)
CICC Analyst forecast on DE:TWY
Unknown Analyst
CICC
Not Ranked
CICC
€0.51
Buy
55.22%
Upside
Reiterated
09/21/26
CICC Sticks to Its Buy Rating for Alibaba Health Information Technology (ALBHF)
Morgan Stanley Analyst forecast on DE:TWY
Alexis Yan
Morgan Stanley
Morgan Stanley
€0.48
Sell
44.87%
Upside
Reiterated
05/15/26
Morgan Stanley’s Alexis Yan Reiterates Sell on Alibaba Health Amid Weak Earnings Momentum and High Upfront Investment Costs
Bank of America Securities Analyst forecast on DE:TWY
Unknown Analyst
Bank of America Securities
Not Ranked
Bank of America Securities
€0.68
Buy
106.96%
Upside
Reiterated
04/14/26
Bank of America Securities Reaffirms Their Buy Rating on Alibaba Health Information Technology (ALBHF)
UOB Kay Hian Analyst forecast on DE:TWY
Unknown Analyst
UOB Kay Hian
Not Ranked
UOB Kay Hian
€0.68
Buy
106.96%
Upside
Reiterated
04/14/26
Alibaba Health Information Technology (ALBHF) Gets a Buy from UOB Kay Hian
GF Securities Analyst forecast on DE:TWY
Unknown Analyst
GF Securities
Not Ranked
GF Securities
€0.84→€0.72
Buy
116.96%
Upside
Reiterated
04/09/26
GF Securities Sticks to Their Buy Rating for Alibaba Health Information Technology (ALBHF)
CLSA Analyst forecast on DE:TWY
Unknown Analyst
CLSA
Not Ranked
CLSA
€0.6
Buy
82.81%
Upside
Reiterated
04/08/26
CLSA Reaffirms Their Buy Rating on Alibaba Health Information Technology (ALBHF)
UBS Analyst forecast on DE:TWY
Unknown Analyst
UBS
Not Ranked
UBS
€0.47
Sell
41.42%
Upside
Reiterated
04/07/26
UBS Remains a Sell on Alibaba Health Information Technology (ALBHF)
HSBC Analyst forecast on DE:TWY
Unknown Analyst
HSBC
Not Ranked
HSBC
€0.74
Hold
124.20%
Upside
Reiterated
02/09/26
Alibaba Health Information Technology (ALBHF) Gets a Hold from HSBC
Citi Analyst forecast on DE:TWY
Unknown Analyst
Citi
Not Ranked
Citi
€1.02
Buy
210.44%
Upside
Reiterated
02/05/26
Citi Sticks to Its Buy Rating for Alibaba Health Information Technology (ALBHF)
Citic Securities Analyst forecast on DE:TWY
Unknown Analyst
Citic Securities
Not Ranked
Citic Securities
€1.38
Buy
317.37%
Upside
Reiterated
01/15/26
Guotai Haitong Analyst forecast on DE:TWY
Unknown Analyst
Guotai Haitong
Not Ranked
Guotai Haitong
€0.65
Buy
96.27%
Upside
Reiterated
12/03/25
Alibaba Health Information Technology (ALBHF) Gets a Buy from Guotai Haitong
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Jefferies Analyst forecast on DE:TWY
Hongda Zhong
Jefferies
Not Ranked
Jefferies
€0.51
Buy
55.22%
Upside
Reiterated
09/30/26
Wall Street Analysts Are Bullish on Top Healthcare Picks
Goldman Sachs Analyst forecast on DE:TWY
Lincoln Kong
Goldman Sachs
Goldman Sachs
€0.48→€0.41
Hold
24.17%
Upside
Reiterated
09/22/26
Analysts' Opinions Are Mixed on These Healthcare Stocks: Cardiol Therapeutics (NASDAQ: CRDL), Tyra Bioscience (NASDAQ: TYRA) and Alibaba Health Information Technology (Other OTC: ALBHF)
Huatai Securities Analyst forecast on DE:TWY
Unknown Analyst
Huatai Securities
Not Ranked
Huatai Securities
€0.48
Buy
46.25%
Upside
Reiterated
09/22/26
Huatai Securities Remains a Buy on Alibaba Health Information Technology (ALBHF)
CICC Analyst forecast on DE:TWY
Unknown Analyst
CICC
Not Ranked
CICC
€0.51
Buy
55.22%
Upside
Reiterated
09/21/26
CICC Sticks to Its Buy Rating for Alibaba Health Information Technology (ALBHF)
Morgan Stanley Analyst forecast on DE:TWY
Alexis Yan
Morgan Stanley
Morgan Stanley
€0.48
Sell
44.87%
Upside
Reiterated
05/15/26
Morgan Stanley’s Alexis Yan Reiterates Sell on Alibaba Health Amid Weak Earnings Momentum and High Upfront Investment Costs
Bank of America Securities Analyst forecast on DE:TWY
Unknown Analyst
Bank of America Securities
Not Ranked
Bank of America Securities
€0.68
Buy
106.96%
Upside
Reiterated
04/14/26
Bank of America Securities Reaffirms Their Buy Rating on Alibaba Health Information Technology (ALBHF)
UOB Kay Hian Analyst forecast on DE:TWY
Unknown Analyst
UOB Kay Hian
Not Ranked
UOB Kay Hian
€0.68
Buy
106.96%
Upside
Reiterated
04/14/26
Alibaba Health Information Technology (ALBHF) Gets a Buy from UOB Kay Hian
GF Securities Analyst forecast on DE:TWY
Unknown Analyst
GF Securities
Not Ranked
GF Securities
€0.84→€0.72
Buy
116.96%
Upside
Reiterated
04/09/26
GF Securities Sticks to Their Buy Rating for Alibaba Health Information Technology (ALBHF)
CLSA Analyst forecast on DE:TWY
Unknown Analyst
CLSA
Not Ranked
CLSA
€0.6
Buy
82.81%
Upside
Reiterated
04/08/26
CLSA Reaffirms Their Buy Rating on Alibaba Health Information Technology (ALBHF)
UBS Analyst forecast on DE:TWY
Unknown Analyst
UBS
Not Ranked
UBS
€0.47
Sell
41.42%
Upside
Reiterated
04/07/26
UBS Remains a Sell on Alibaba Health Information Technology (ALBHF)
HSBC Analyst forecast on DE:TWY
Unknown Analyst
HSBC
Not Ranked
HSBC
€0.74
Hold
124.20%
Upside
Reiterated
02/09/26
Alibaba Health Information Technology (ALBHF) Gets a Hold from HSBC
Citi Analyst forecast on DE:TWY
Unknown Analyst
Citi
Not Ranked
Citi
€1.02
Buy
210.44%
Upside
Reiterated
02/05/26
Citi Sticks to Its Buy Rating for Alibaba Health Information Technology (ALBHF)
Citic Securities Analyst forecast on DE:TWY
Unknown Analyst
Citic Securities
Not Ranked
Citic Securities
€1.38
Buy
317.37%
Upside
Reiterated
01/15/26
Guotai Haitong Analyst forecast on DE:TWY
Unknown Analyst
Guotai Haitong
Not Ranked
Guotai Haitong
€0.65
Buy
96.27%
Upside
Reiterated
12/03/25
Alibaba Health Information Technology (ALBHF) Gets a Buy from Guotai Haitong
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
AORTArtivion
MDWDMediwound
IMUXImmunic
RZLTRezolute
DFTXDefinium Therapeutics
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Alibaba Health Information Technology

3 Months
Alexis YanMorgan Stanley
Success Rate
3/3 ratings generated profit
100%
Average Return
+9.37%
Copying Alexis Yan's trades and holding each position for 3 Months would result in 100.00% of your transactions generating a profit, with an average return of +9.37% per trade.
1 Year
Alexis YanMorgan Stanley
Success Rate
3/3 ratings generated profit
100%
Average Return
+36.20%
Copying Alexis Yan's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +36.20% per trade.
2 Years
Alexis YanMorgan Stanley
Success Rate
3/3 ratings generated profit
100%
Average Return
+36.20%
Copying Alexis Yan's trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +36.20% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

TWY Analyst Recommendation Trends

Rating
Jun 26
Jul 26
Aug 26
Sep 26
Oct 26
Strong Buy
1
1
0
2
2
Buy
7
2
0
1
1
Hold
2
1
0
1
1
Sell
2
1
0
0
0
Strong Sell
0
0
0
0
0
total
12
5
0
4
4
In the current month, TWY has received 3 Buy Ratings, 1 Hold Ratings, and 0 Sell Ratings. TWY average Analyst price target in the past 3 months is 0.48.
Each month's total comprises the sum of three months' worth of ratings.

TWY Financial Forecast

TWY Earnings Forecast

Next quarter’s earnings estimate for TWY is <€0.01 with a range of <€0.01 to <€0.01. The previous quarter’s EPS was <€0.01. TWY beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year TWY has Performed in-line its overall industry.
Next quarter’s earnings estimate for TWY is <€0.01 with a range of <€0.01 to <€0.01. The previous quarter’s EPS was <€0.01. TWY beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year TWY has Performed in-line its overall industry.

TWY Sales Forecast

Next quarter’s sales forecast for TWY is €2.41B with a range of €2.39B to €2.42B. The previous quarter’s sales results were €2.22B. TWY beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year TWY has Performed in-line its overall industry.
Next quarter’s sales forecast for TWY is €2.41B with a range of €2.39B to €2.42B. The previous quarter’s sales results were €2.22B. TWY beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year TWY has Performed in-line its overall industry.

TWY Stock Forecast FAQ

What is DE:TWY’s average 12-month price target, according to analysts?
Based on analyst ratings, Alibaba Health Information Technology Ltd.’s 12-month average price target is 0.48.
    What is DE:TWY’s upside potential, based on the analysts’ average price target?
    Alibaba Health Information Technology Ltd. has 45.22% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is Alibaba Health Information Technology Ltd. a Buy, Sell or Hold?
          Alibaba Health Information Technology Ltd. has a consensus rating of Strong Buy, which is based on 3 buy ratings, 1 hold ratings and 0 sell ratings.
            What is Alibaba Health Information Technology Ltd.’s share price target?
            The average share price target for Alibaba Health Information Technology Ltd. is 0.48. This is based on 4 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst share price target is €0.51 ,and the lowest forecast is €0.41. The average share price target represents 45.22% Increase from the current price of €0.33.
              What do analysts say about Alibaba Health Information Technology Ltd.?
              Alibaba Health Information Technology Ltd.’s analyst rating consensus is a Strong Buy. This is based on the ratings of 4 Wall Streets Analysts.
                How can I buy shares of Alibaba Health Information Technology Ltd.?
                To buy shares of DE:TWY, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.